FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101539 [Registered on: 19/01/2026] Trial Registered Prospectively
Last Modified On: 19/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   In this study, we will find out how putting ropivacaine directly into the wound after a caesarean section helps to reduce pain after surgery.” 
Scientific Title of Study   Effect of local wound infiltration with ropivacaine in post operative pain relief after caesarean section 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr ANJU YADAV  
Designation  THIRD YEAR RESIDENT 
Affiliation  B . J . MEDICAL COLLEGE AND CIVIL HOSPITALASARWA AHMEDABAD 
Address  F3 FIRST FLOOR DEPARTMENT OF ANAESTHESIA CIVIL HOSPITAL ASARWA AHMEDABAD
NIL
Ahmadabad
GUJARAT
380016
India 
Phone  8851714576  
Fax    
Email  anjalianjuyadav17@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR BHAVANA RAVAL 
Designation  PROFESSOR H G , DEPARTMENT OF ANAESTHESIOLOGY 
Affiliation  B. J. MEDICAL COLLEGE AND CIVIL HOSPITAL ASARWA AHMEDABAD 
Address  F3 FIRST FLOOR DEPARTMENT OF ANAESTHESIA CIVIL HOSPITAL ASARWA AHMEDABAD
NIL
Ahmadabad
GUJARAT
380016
India 
Phone  9426373182  
Fax    
Email  drbhavanaraval@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DR BHAVANA RAVAL 
Designation  PROFESSOR H G , DEPARTMENT OF ANAESTHESIOLOGY 
Affiliation  B. J. MEDICAL COLLEGE AND CIVIL HOSPITAL ASARWA AHMEDABAD 
Address  F3 FIRST FLOOR DEPARTMENT OF ANAESTHESIA CIVIL HOSPITAL ASARWA AHMEDABAD
NIL
Ahmadabad
GUJARAT
380016
India 
Phone  9426373182  
Fax    
Email  drbhavanaraval@yahoo.com  
 
Source of Monetary or Material Support  
GOVERNMENT OF GUJARAT HEALTH AND FAMILY WELFARE DEPARTMENT 7TH FLOOR NEW SACHIVALAYA GANDHINAGAR 382010 GUJARAT INDIA 
 
Primary Sponsor  
Name  GOVERNMENT OF GUJARAT 
Address  HEALTH AND FAMILY WELFARE DEPARTMENT 7TH FLOOR NEW SACHIVALAYA GANDHINAGAR 382010 GUJARAT INDIA 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr ANJU YADAV  1200 BED HOSPITAL  OBSTETRIC OPERATION THEATRE 1200 BED HOSPITAL CIVIL HOSPITAL CAMPUS ASARWA AHMEDABAD
Ahmadabad
GUJARAT 
08851714576

anjalianjuyadav17@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
THE INSTITUTIONAL ETHICS COMMITTEE B.J. MEDICAL COLLEGE AND CIVIL HOSPITAL AHMEDABAD  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O00-O9A||Pregnancy, childbirth and the puerperium,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  LOCAL WOUND INFILTERATION OF NORMAL SALINE   AT THE TIME OF SKIN CLOSURE NORMAL SALINE 20 ML WILL BE INFILTERATED IN SUBCUTANEOUS TISSUE.  
Intervention  LOCAL WOUND INFILTERATION OF ROPIVACAINE   AT THE TIME OF SKIN CLOSURE ROPIVACAINE 0.5% TOTAL VOLUME 20ML WILL BE INFILTERATED IN SUBCUTANEOUS TISSUE. 
 
Inclusion Criteria  
Age From  19.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  ASA GRADE I AND II,ELECTIVE SURGERY 
 
ExclusionCriteria 
Details  PATIENT REFUSAL,ALLERGY TO LOCAL ANAESTHETIC DRUG ,PATIENT WITH PREGNANCY INDUCED HYPERTENSION , PATIENT WITH PRE EXISTING CARDIORESPIRATORY DISEASES,PATIENT WITH BLEEDING DISORDER. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
TO EVALUATE POST OPERATIVE PAIN SCORE  POST OPERATIVE 24 HOURS 
 
Secondary Outcome  
Outcome  TimePoints 
POSTOPERATIVE NEED OF RESCUE ANALGESIA, HEMODYNAMIC MONITORING AND COMPLICATIONS.  POSTOPERATIVE 24 HOURS 
 
Target Sample Size   Total Sample Size="110"
Sample Size from India="110" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   THE RATE OF CAESAREAN SECTION HAS BEEN ON PROGRESSIVE RISE EVER SINCE ITS ASSOCIATON WITH IMPROVED FETAL PROGNOSIS.POSTOPERATIVE PAIN AFTER CAESAREAN SECTION IS ONE OF MOST PREVENTABLE ADVERSE OUTCOME OF SURGERY. ROPIVACAINE IS A LOCAL ANAESTHETIC DRUG WHICH ACTS BY INHIBITING THE TRANSMISSION OF NOXIOUS STIMULI FROM THE SITE OF INJURY BY REVERSIBLE HYPERPOLARIZATION OF PERIPHERAL NERVE FIBERS.THIS STUDY IS TO ESTABILISH THE EFFICACY OF LOCAL WOUND INFILTERATION WITH ROPIVACAINE 0.5% AS ANALGESIC. 
Close